This resulted in the development of favored anti-tumor response (Th1 differentiation, NK and CD8 + CTL recruitment) and down-regulation of immune suppression signatures (PD-1, CTLA-4, TIM-3) [20]. This evidence concerns the gene CTLA4 and neoplasm.